Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Implantable defibrillator therapy.

A M W Alings1

  • 1Department of Cardiology, Amphia Hospital, Molengracht 21, 4818 CK Breda, The Netherlands. Malings@Amphia.nl

The Netherlands Journal of Medicine
|August 16, 2003
PubMed
Summary

Implantable cardioverter-defibrillators (ICDs) are more effective than antiarrhythmic drugs (AADs) in preventing sudden cardiac death (SCD). ICDs show consistent benefits in both secondary and primary prevention for heart attack survivors with reduced ejection fraction.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Beta-blockers after a myocardial infarction: when to discontinue safely?]

Nederlands tijdschrift voor geneeskunde·2021
Same author

Metastatic right ventricular obstruction.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2015
Same author

Anomalous origin of the left coronary artery connected to the pulmonary artery in a 31-year-old woman.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2015
Same author

Not so fast..

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2015
Same author

RESPONSE study: Randomised Evaluation of Secondary Prevention by Outpatient Nurse SpEcialists: Study design, objectives and expected results.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2009
Same author

[Suicide attempt with sotalol: a proarrhythmic intoxication].

Nederlands tijdschrift voor geneeskunde·2007

Area of Science:

  • Cardiology
  • Electrophysiology
  • Preventive Medicine

Background:

  • Sudden cardiac death (SCD) is a leading cause of mortality globally.
  • Antiarrhythmic drugs (AADs) have shown limited efficacy in preventing SCD, with beta-blockers being a notable exception.
  • This led to the development of trials comparing implantable cardioverter-defibrillators (ICDs) against drug therapy for SCD prevention.

Purpose of the Study:

  • To evaluate the efficacy of implantable cardioverter-defibrillators (ICDs) compared to antiarrhythmic drugs (AADs) in preventing sudden cardiac death (SCD).
  • To assess ICD benefit in both secondary and primary prevention settings, particularly in patients with a history of myocardial infarction and left ventricular dysfunction.

Main Methods:

  • Meta-analysis of three large randomized secondary prevention trials in patients resuscitated from ventricular tachycardia (VT) or ventricular fibrillation (VF) after myocardial infarction.
  • Analysis of three large randomized primary prevention trials in patients with prior myocardial infarction and left ventricular dysfunction.

Main Results:

  • Meta-analysis confirmed a consistent benefit of ICD therapy in secondary prevention post-myocardial infarction.
  • ICD therapy also demonstrated significant benefit in primary prevention for patients with prior myocardial infarction and left ventricular dysfunction.
  • The beneficial effect of ICDs was most pronounced in patients with the lowest left ventricular ejection fraction (26-30%).

Conclusions:

  • Implantable cardioverter-defibrillators (ICDs) are superior to antiarrhythmic drugs (AADs) for preventing sudden cardiac death (SCD) in specific patient populations.
  • ICD implantation is evidence-based for secondary prevention in patients with non-ischaemic dilated cardiomyopathy and low ejection fractions.
  • Further research may be warranted to optimize ICD use in primary prevention for diverse cardiomyopathies.

Related Experiment Videos